End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15,430 KRW | -0.84% | +0.98% | -15.03% |
2023 | Il Dong Pharmaceutical Eyes Approval for to Manufacture Japan's COVID-19 Treatment in South Korea | MT |
2023 | Il Dong Pharmaceutical Introduces New R&D Unit Yunovia | MT |
Chart calendar Ildong Pharmaceutical Co., Ltd.
Upcoming events on Ildong Pharmaceutical Co., Ltd.
Past events on Ildong Pharmaceutical Co., Ltd.
07/02/2024 | Q4 2023 Earnings Release |
14/05/2023 | Q1 2023 Earnings Release |
15/03/2023 | Q4 2022 Earnings Release |
12/01/2023 | Roadshow - Day - 2 |
11/01/2023 | Roadshow - Day - 1 |
13/11/2022 | Q3 2022 Earnings Release |
15/08/2022 | Interim 2022 Earnings Release |
15/05/2022 | Q1 2022 Earnings Release |
16/08/2021 | Interim 2021 Earnings Release |
16/05/2021 | Q1 2021 Earnings Release |
17/03/2021 | FY 2020 Earnings Release |
29/03/2020 | FY 2019 Earnings Release |
13/11/2019 | Q3 2019 Earnings Release |
14/05/2019 | Q1 2019 Earnings Release |
19/02/2018 | FY 2017 Earnings Release |
Past dividends on Ildong Pharmaceutical Co., Ltd.
26/12/2018 | Annual 400 KRW |
26/12/2017 | Annual 400 KRW |
27/12/2016 | Annual 300 KRW |
Annual results
Fiscal Period | December | 2019 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Net sales Billions KRW | Released Forecast Spread | 517 532 -2.78% | 636 645 -1.42% | 598 597 0.24% | 640 |
EBITDA Billions KRW | Released Forecast Spread | 25,7 53,8 -52.17% | -43,0 -15,0 -186.54% | 0,00 -17,0 - | 81,0 |
EBIT Billions KRW | Released Forecast Spread | -1,90 26,1 -107.28% | -72,1 -41,0 -75.97% | -40,9 -41,0 0.21% | 55,8 |
Earnings before Tax (EBT) Billions KRW | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -82,0 -96,5 14.98% | 39,1 |
Net income Billions KRW | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -71,5 -93,7 23.71% | 35,2 |
EPS KRW | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 -3 338 - | 1 255 |
Announcement Date | 14/02/20 | 09/02/23 | 08/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q2 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|
Net sales Billions KRW | Released Forecast Spread | 162 143 13.31% | 149 148 0.99% | 151 | 158 | 164 | 166 |
EBIT Billions KRW | Released Forecast Spread | -22,0 17,0 -229.59% | 12,9 | 10,1 | 14,2 | 18,6 | |
Earnings before Tax (EBT) Billions KRW | Released Forecast Spread | 0,02 -14,5 100.12% | 12,4 | 6,20 | 8,20 | 12,4 | |
Net income Billions KRW | Released Forecast Spread | 7,50 -14,7 151.03% | 11,1 | 5,50 | 7,40 | 11,2 | |
Announcement Date | 27/07/22 | 08/02/24 | - | - | - | - |
06/05/2024 | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED: Q4 2024 Earnings Release (Projected) |
06/05/2024 | EVOLUS, INC.: Q1 2024 Earnings Release |
06/05/2024 | DR. REDDY'S LABORATORIES LIMITED: Q4 2024 Earnings Release |
06/05/2024 | PACIRA BIOSCIENCES, INC.: Q1 2024 Earnings Release |
06/05/2024 | BLAU FARMACÊUTICA S.A.: Q1 2024 Earnings Release |
07/05/2024 11:30 | PERRIGO COMPANY PLC: Q1 2024 Earnings Release |
07/05/2024 21:00 | OCULAR THERAPEUTIX, INC.: Q1 2024 Earnings Release |
07/05/2024 21:01 | LIGAND PHARMACEUTICALS INCORPORATED: Q1 2024 Earnings Release |
07/05/2024 21:05 | SIGA TECHNOLOGIES, INC.: Q1 2024 Earnings Release |
07/05/2024 | IMMUNOCORE HOLDINGS PLC: Q1 2024 Earnings Release (Projected) |
Past sector events for Ildong Pharmaceutical Co., Ltd.
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- A249420 Stock
- Calendar Ildong Pharmaceutical Co., Ltd.